What defines 'cure' after liver resection for colorectal metastases? Results after 10 years of follow-up.

scientific article

What defines 'cure' after liver resection for colorectal metastases? Results after 10 years of follow-up. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1477-2574.2010.00155.X
P932PMC publication ID2873647
P698PubMed publication ID20590894
P5875ResearchGate publication ID44887713

P50authorStephen J. WigmoreQ48085030
Luca Antonio AldrighettiQ88601450
P2093author name stringO James Garden
Rowan W Parks
Martin Bodingbauer
Carlo Pulitanò
Gianfranco Ferla
Federico Castillo
P2860cites workAdjuvant chemotherapy improves survival after resection of hepatic colorectal metastases: analysis of data from two continentsQ31111685
Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive casesQ33874670
Trends in long-term survival following liver resection for hepatic colorectal metastasesQ34523502
Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survivalQ34551117
Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastasesQ34557044
Resection of the liver for colorectal carcinoma metastases. A multi-institutional study of long-term survivorsQ34680919
Actual 10-year survival after resection of colorectal liver metastases defines cure.Q34699863
Expanding criteria for resectability of colorectal liver metastasesQ37075581
Resection of liver metastases in colorectal cancer--competitive analysis of treatment results in synchronous versus metachronous metastasesQ41186718
Guidelines for resection of colorectal cancer liver metastases.Q42150472
Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural historyQ43990247
Resection of hepatic metastases from colorectal cancerQ44454061
R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery?Q45674652
Results of preoperative hepatic arterial infusion chemotherapy in patients undergoing liver resection for colorectal liver metastasesQ45895324
Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinomaQ46816802
Size of surgical margin does not influence recurrence rates after curative liver resection for colorectal cancer liver metastasesQ47287366
Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastasesQ49186620
Analysis of prognostic risk factors in hepatic resection for metastatic colorectal carcinoma with special reference to the surgical marginQ73649108
Ninety-six five-year survivors after liver resection for metastatic colorectal cancerQ73954807
Factors influencing survival of patients undergoing hepatectomy for colorectal metastasesQ77319884
Long-term characteristics of 5-year survivors after liver resection for colorectal metastasesQ79604161
Analysis of prognostic factors influencing long-term survival after hepatic resection for metastatic colorectal cancerQ79917337
Quantification of risk of a positive (R1) resection margin following hepatic resection for metastatic colorectal cancer: an aid to clinical decision-makingQ80554863
Liver surgery for colorectal metastases: results after 10 years of follow-up. Long-term survivors, late recurrences, and prognostic role of morbidityQ81234867
P433issue4
P304page(s)244-249
P577publication date2010-05-01
P1433published inHepato Pancreato BiliaryQ15756742
P1476titleWhat defines 'cure' after liver resection for colorectal metastases? Results after 10 years of follow-up
P478volume12

Reverse relations

cites work (P2860)
Q38091102A systematic review of a liver-first approach in patients with colorectal cancer and synchronous colorectal liver metastases
Q37933143A systematic review of clinical response and survival outcomes of downsizing systemic chemotherapy and rescue liver surgery in patients with initially unresectable colorectal liver metastases
Q38092734A systematic review of repeat hepatectomy for recurrent colorectal liver metastases.
Q36953786A systematic review of two-stage hepatectomy in patients with initially unresectable colorectal liver metastases
Q49887458Actual 10-year survival after hepatic resection of colorectal liver metastases: what factors preclude cure?
Q38852221An updated systematic review of the evolution of ALPPS and evaluation of its advantages and disadvantages in accordance with current evidence
Q37623502Can we improve the clinical risk score? The prognostic value of p53, Ki-67 and thymidylate synthase in patients undergoing radical resection of colorectal liver metastases
Q38696070Colorectal Cancer Liver Metastases and Concurrent Extrahepatic Disease Treated With Resection
Q26778009Colorectal cancer: Metastases to a single organ
Q43798315Colorectal liver metastasis in the setting of lymph node metastasis: defining the benefit of surgical resection
Q50077917Comments to "Long-Term Survival Benefit and Potential for Cure After R1 Resection for Colorectal Liver Metastases".
Q51014362Cost-utility analysis of operative versus non-operative treatment for colorectal liver metastases.
Q35653302Current state of surgical treatment of liver metastases from colorectal cancer
Q26864128Designing liver resections and pushing the envelope with resections for hepatic colorectal metastases
Q97074205Early T Stage Is Associated With Poor Prognosis in Patients With Metastatic Liver Colorectal Cancer
Q42006606Effect of Remote Ischaemic Preconditioning on Liver Injury in Patients Undergoing Major Hepatectomy for Colorectal Liver Metastasis: A Pilot Randomised Controlled Feasibility Trial
Q93000188Evaluation of Red Cell Distribution Width to Lymphocyte Ratio as Potential Biomarker for Detection of Colorectal Cancer
Q40513991Impact of totally laparoscopic combined management of colorectal cancer with synchronous hepatic metastases on severity of complications: a propensity-score-based analysis
Q38225773Laparoscopic approach to a planned two-stage hepatectomy for bilobar colorectal liver metastases.
Q87621611Liver resection for colorectal metastases: results and prognostic factors with 10-year follow-up
Q43661052Parenchyma-preserving hepatic resection for colorectal liver metastases
Q36915703Patient perceptions regarding the likelihood of cure after surgical resection of lung and colorectal cancer.
Q40261480Potential of a cure in patients with colorectal liver metastases and concomitant extrahepatic disease.
Q37876340Predictors of long-term survival in patients with colorectal liver metastases: a single center study and review of the literature
Q26774687Preoperative selection of patients with colorectal cancer liver metastasis for hepatic resection
Q58695102Proposal of Two Prognostic Models for the Prediction of 10-Year Survival after Liver Resection for Colorectal Metastases
Q40118086Radiofrequency ablation or resection for small colorectal liver metastases - a plea for caution
Q37482898Resection margin influences the outcome of patients with bilobar colorectal liver metastases
Q36501711Role of a liver-first approach for synchronous colorectal liver metastases
Q39063517Strategies to Increase the Resectability of Patients with Colorectal Liver Metastases: A Multi-center Case-Match Analysis of ALPPS and Conventional Two-Stage Hepatectomy.
Q37977308Systematic review and meta-analysis of follow-up after hepatectomy for colorectal liver metastases.
Q49580510The Impact of Primary Tumor Location on Long-Term Survival in Patients Undergoing Hepatic Resection for Metastatic Colon Cancer
Q47741359Thymidylate synthase: a predictive biomarker in resected colorectal liver metastases receiving 5-FU treatment
Q37008553Use of the word "cure" in oncology
Q34576835Whole-liver CT texture analysis in colorectal cancer: Does the presence of liver metastases affect the texture of the remaining liver?
Q39018756miR-30b regulates migration and invasion of human colorectal cancer via SIX1.

Search more.